[Point-of-care-testing--the intensive care laboratory]
- PMID: 10073241
- DOI: 10.1007/s001010050661
[Point-of-care-testing--the intensive care laboratory]
Abstract
After successful centralization of laboratory analyses since more than 30 years, advances in biosensors, microprocessors, measurement of undiluted whole blood and miniaturization of laboratory analyzers are leading nowadays more and more to a re-decentralization in the laboratory medicine. Point-of-care-testing (POCT), which is defined as any laboratory test performed outside central or decentralized laboratories, is becoming more and more popular. The theoretical advantages of POCT are faster turn-around-times (TAT), more rapid medical decisions, avoidance of sample identification and sample transport problems and the need of only small specimen volumes. These advantages are frequently mentioned, but are not associated with a clear clinical benefit. The disadvantages of POCT such as incorrect handling and/or maintenance of the analyzers by nontrained clinical staff, inadequate or even absent calibrations and/or quality controls, lack of cost-effectiveness because of an increased number of analyzers and more expensive reagents, insufficient documentation and difficult comparability of the obtained POCT-results with routine laboratory results, are strongly evident. According to the authors' opinion the decision for the establishing of POCT has only to be made in a close co-operation between physicians and laboratorians in order to vouch for necessity and high quality of the analyses. Taking the local situation into consideration (24-h-central laboratory, etc.) the spectrum of parameters measured by means of POCT should be rigorously restricted to the vital functions. Such analytes should be: hemoglobin or hematocrit, activated whole blood clotting time, blood gases, sodium, potassium, ionized calcium, glucose, creatinine, ammonia and lactate.
Similar articles
-
Point of care: diagnostics in hemostasis--the wrong direction?Clin Appl Thromb Hemost. 2003 Jul;9(3):191-5. doi: 10.1177/107602960300900302. Clin Appl Thromb Hemost. 2003. PMID: 14507106 Review.
-
[Quality assurance of point of care testing].Rinsho Byori. 2012 Dec;60(12):1163-6. Rinsho Byori. 2012. PMID: 23427698 Japanese.
-
[Point of care testing from clinical laboratory].Rinsho Byori. 2002 Oct;50(10):936-9. Rinsho Byori. 2002. PMID: 12451671 Review. Japanese.
-
Quality and timeliness in medical laboratory testing.Anal Bioanal Chem. 2009 Mar;393(5):1499-504. doi: 10.1007/s00216-008-2349-5. Epub 2008 Sep 14. Anal Bioanal Chem. 2009. PMID: 18791707 Review.
-
Laboratory testing during critical care transport: point-of-care testing in air ambulances.Clin Chem Lab Med. 2010 Jul;48(7):955-61. doi: 10.1515/CCLM.2010.190. Clin Chem Lab Med. 2010. PMID: 20406127 Review.
Cited by
-
SARS-CoV-2 in Mexico: Beyond Detection Methods, Scope and Limitations.Diagnostics (Basel). 2021 Jan 14;11(1):124. doi: 10.3390/diagnostics11010124. Diagnostics (Basel). 2021. PMID: 33466884 Free PMC article. Review.
-
Lyme Disease Biosensors: A Potential Solution to a Diagnostic Dilemma.Biosensors (Basel). 2020 Sep 28;10(10):137. doi: 10.3390/bios10100137. Biosensors (Basel). 2020. PMID: 32998254 Free PMC article. Review.
-
NiADA (Non-invasive Anemia Detection App), a Smartphone-Based Application With Artificial Intelligence to Measure Blood Hemoglobin in Real-Time: A Clinical Validation.Cureus. 2024 Jul 26;16(7):e65442. doi: 10.7759/cureus.65442. eCollection 2024 Jul. Cureus. 2024. PMID: 39071070 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical